Narrow-Spectrum Agents is an antiseizure medication class characterized by selective efficacy against specific types of seizures or epilepsy syndromes, distinguishing it from broader-acting agents through its limited therapeutic range.
39
Publications
1.7K
Citations
193
Authors
65
Institutions
Publications per year
2017–2026
17
Variants
Narrow-spectrum Antiseizure Medications
Parents
Publications
39
Basis of narrow-spectrum activity of fidaxomicin on Clostridioides difficile
Xinyun Cao, Hande Boyaci, James Chen et al. · Nature · 2022 · 57 citations · Full text
Extended- Versus Narrower-Spectrum Antibiotics for Appendicitis
Matthew P. Kronman, Assaf P. Oron, Rachael K. Ross et al. · PEDIATRICS · 2016 · 55 citations
Pharmacy, Child Health, Pediatrics +15
1–5 of 39
Authors
193
- SJ
3
h-index
- FE
2
h-index
- MP
2
h-index
- CP
2
h-index
- DB
2
h-index
1–5 of 193
Institutions
65
Centers for Disease Control and Prevention
Atlanta, United States
3 h-index
5 publications
1.1K citations
Harvard University
Cambridge, United States
3 h-index
10 publications
281 citations
University of Utah
Salt Lake City, United States
2 h-index
3 publications
993 citations
Seattle Children's Hospital
Seattle, United States
2 h-index
2 publications
89 citations
Scripps Research Institute
San Diego, United States
2 h-index
12 publications
334 citations
Boston Children's Hospital
Boston, United States
2 h-index
13 publications
330 citations
University College London
London, United Kingdom
2 h-index
2 publications
72 citations
University of Washington
Seattle, United States
2 h-index
5 publications
254 citations
1–8 of 65
Venues
- PubMed
Repository · 5 publications · 126 citations
5
h-index
- Journal of Medicinal Chemistry
3 publications · 106 citations
3
h-index
- PEDIATRICS
2 publications · 333 citations
2
h-index
- British Journal of Pharmaceutical Research
2 publications · 36 citations
2
h-index
- Clinical Infectious Diseases
CID · 2 publications · 101 citations
2
h-index
1–5